General information

Omega-3 fatty acids are long-chain polyunsaturated fatty acids. The parent fatty acid of this group is alpha-linolenic acid, an essential fatty acid that the body is unable to synthesize; alpha-linolenic acid can be converted in the body to eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). In animals and man, these acids reduce the production of several compounds that are involved in inflammation and thrombosis, such as eicosanoids (prostaglandins, thromboxanes, prostacyclin, and leukotrienes) and cytokines (interleukin II-1) [ ]. The extent of the conversion of alpha-linolenic acid to EPA and DHA is unclear. The conversion process appears to be inhibited by a high intake of linoleic acid, another essential fatty acid [ ]. In addition, alpha-linolenic acid is found in dark green vegetables and the oils of certain nuts and seeds, especially rape seeds and soya beans.

Oily fish and extracted fish oils contain high concentrations of EPA and DHA. Fish oils also contain vitamins A and D. Oil derived from cod, halibut, or shark liver, or from fish body, typically contains about 200 mg/ml of long-chain omega-3 fatty acids. In addition, cod liver oil provides 50 micrograms/ml of vitamin A and 2 micrograms/ml of vitamin D. Many fish oil supplements are artificially enriched with omega-3 fatty acids.

The safety of drugs containing EPA and DHA has been reviewed; the reported adverse reactions were similar to those in control groups [ ]. Even 3–7 g/day for several months did not change liver enzyme activities, and there were no bleeding problems. Consumption of fish oils reduces the resistance of LDL to oxidative modification, and this is partly opposed by the addition of vitamin E [ ]. Belching or eructation with a fishy taste or smell, vomiting, flatulence, diarrhea, and constipation are relatively common.

Organs and systems

Cardiovascular

Some of the beneficial effects of fish oils after acute myocardial infarction have been attributed to an antidysrhythmic effect on the heart [ ]. However, the results of a randomized trial in 200 patients with implantable cardioverter defibrillators are at variance with this: the rate of cardioversion was higher in those taking fish oils 1.8 g/day than in a control group who took olive oil [ ]. The lack of benefit and the suggestion that fish oil supplementation may increase the risk of ventricular tachycardia or ventricular fibrillation in some patients with implantable cardioverter defibrillators can reasonably be interpreted as evidence that the routine use of fish oil supplementation in patients with implantable cardioverter defibrillators and recurrent ventricular dysrhythmias should be avoided.

Respiratory

Fish oils can cause exacerbation of asthma in aspirin-sensitive patients [ ].

Cod liver oil supplements can cause lipoid pneumonia [ ].

You're Reading a Preview

Become a Clinical Tree membership for Full access and enjoy Unlimited articles

Become membership

If you are a member. Log in here